- ▼ English
- Korean
GBIOLOGICS
Biotechnology company
Biotechnology company
| Products | Indications |
| Protein | - EPO(Anemia) |
| Antibody |
- Abciximab (acute myocardial infarction) - Acute Leukemia |
| Gene Therapy | - Prostate cancer |
| Cell Therapy |
- Lung cancer - B cell lymphoma |
| Chemical |
- Water-soluble UDCA for Wet AMD(oral use) - Sepsis - EC-18 for Neutropenia (oral use) |
| Vaccine |
- Cholera - Breast cancer |
| Consulting contents | Outcome |
|
· Licensing In/Out · Co-Development · Assessment of the marketability and feasibility of technology · Business feasibility analysis · Writing business proposals and contracts in English |
· In-Licensing agreement with a Japanese company · Licensing agreement with a Dutch company · Distribution and sales rights agreement between domestic companies · Technology transfer and joint development agreement between domestic companies |
